Corning Incorporated vs 22nd Century Group Inc — how do they compare? Corning Incorporated trades at $156.12 (market cap $150.10B), while 22nd Century Group Inc trades at $4.27 (market cap $1.52M). The key difference: Corning Incorporated is far larger — about 98750× 22nd Century Group Inc's market cap, and Corning Incorporated pays a 0.64% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| GLW | XXII | |
|---|---|---|
Market Cap | $150.10B | $1.52M |
Sector | Technology | Technology |
52-Week High | $255.79 | $1.47K |
52-Week Low | $52.97 | $3.90 |
Enterprise Value | $158.27B | -$6.71M |
Dividend Yield | 0.64% | — |
Signals from Pluang's Aura AI — not financial advice
GLW is trading at $156.59, down 16.57% over 24 hours, reflecting a significant pullback from recent highs. The stock shows bearish technical signals but maintains strong fundamentals with revenue growth to $15.63 billion in 2025 and net income of $1.60 billion. Recent earnings beats and analyst optimism around AI-driven optical communication demand provide a positive backdrop despite near-term volatility.
The outlook for GLW is cautiously optimistic, with a consensus price target of $210.10 implying substantial upside. Key opportunities include partnerships with NVIDIA and Amazon in AI infrastructure, while risks involve high valuation multiples and sensitivity to tech sector sentiment. Long-term growth in 5G and automotive glass supports the investment case.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →